Open AccessSevere sinus bradycardia associated with favipiravir in a COVID‐19 patient
Author(s) -
Habib Mhd Baraa,
Elshafei Mohamed,
Rahhal Alaa,
Mohamed Mouhand F. H.
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4566
Subject(s) - medicine , favipiravir , bradycardia , covid-19 , sinus bradycardia , anesthesia , sinus (botany) , intensive care medicine , virology , heart rate , disease , outbreak , infectious disease (medical specialty) , blood pressure , botany , biology , genus
The antiviral medication “favipiravir” should be considered as a possible cause of unexplained sinus bradycardia.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom